Podcast
Questions and Answers
What is a major issue contributing to the lack of success in Alzheimer's disease clinical trials?
What is a major issue contributing to the lack of success in Alzheimer's disease clinical trials?
- Difficulty in designing appropriate clinical trials (correct)
- Too many participants in the trials
- Overwhelming success of previous clinical trials
- Lack of funding for clinical trials
Which type of therapy focuses on targeting tau in Alzheimer's disease?
Which type of therapy focuses on targeting tau in Alzheimer's disease?
- Microglia activation therapy
- Solanezumab
- Gantenerumab (correct)
- Anti-Aβ antibodies
What was the outcome of the clinical trials with Solanezumab and Gantenerumab?
What was the outcome of the clinical trials with Solanezumab and Gantenerumab?
- Only Solanezumab showed positive results
- Both drugs showed significant improvement in cognitive decline
- Neither drug demonstrated significant benefits (correct)
- Only Gantenerumab showed positive results
Why do researchers face challenges in designing clinical trials for Alzheimer's disease therapies?
Why do researchers face challenges in designing clinical trials for Alzheimer's disease therapies?
What is a common focus of therapeutic approaches for addressing Alzheimer's disease?
What is a common focus of therapeutic approaches for addressing Alzheimer's disease?
What are the key therapeutic targets for Alzheimer's disease pathology?
What are the key therapeutic targets for Alzheimer's disease pathology?
Which drug is a non-competitive antagonist at NMDA, 5HT3, and nicotinic acetylcholine receptors?
Which drug is a non-competitive antagonist at NMDA, 5HT3, and nicotinic acetylcholine receptors?
What is the mode of action of Solanezumab in Alzheimer's disease?
What is the mode of action of Solanezumab in Alzheimer's disease?
Gantenerumab primarily targets which aspect of Alzheimer's disease pathology?
Gantenerumab primarily targets which aspect of Alzheimer's disease pathology?
Which treatment option aims to reduce glutamate excitotoxicity in Alzheimer's disease?
Which treatment option aims to reduce glutamate excitotoxicity in Alzheimer's disease?
What is a common feature of Phase II and III trials for Alzheimer's disease treatments?
What is a common feature of Phase II and III trials for Alzheimer's disease treatments?
What do tau tangles correlate better with, in terms of cognitive dysfunction, compared to plaques?
What do tau tangles correlate better with, in terms of cognitive dysfunction, compared to plaques?
What is the primary focus of Aβ immunotherapies?
What is the primary focus of Aβ immunotherapies?
What is the main purpose of attracting immune cells in Aβ immunotherapies?
What is the main purpose of attracting immune cells in Aβ immunotherapies?
In what phase of clinical trials are anti-Aβ antibodies like Solanezumab and Gantenerumab commonly evaluated?
In what phase of clinical trials are anti-Aβ antibodies like Solanezumab and Gantenerumab commonly evaluated?
Which of the following is NOT a proposed mechanism of action for Aβ immunotherapies?
Which of the following is NOT a proposed mechanism of action for Aβ immunotherapies?
What is the key difference between an active and passive immunization approach to Aβ immunotherapies?
What is the key difference between an active and passive immunization approach to Aβ immunotherapies?
Flashcards are hidden until you start studying
